Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination

Yoshiyuki Fujiwara, Shuji Takiguchi, Kiyokazu Nakajima, Hiroshi Miyata, Makoto Yamasaki, Yukinori Kurokawa, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background Our previous phase I study indicated that combination chemotherapy with intraperitoneal docetaxel and S-1 was well tolerated by gastric cancer patients with peritoneal carcinomatosis (PC). This study evaluated the benefits of this combination chemotherapy and subsequent surgery. Patients and Methods Neoadjuvant Intra-Peritoneal and Systemic chemotherapy (NIPS) was introduced to gastric cancer patients with positive cytology or with PC. Two cycles of intraperitoneal chemotherapy with docetaxel combined with S-1, were administrated and gastrectomy with lymph node dissection was performed in cases without macroscopic PC at post-NIPS staging laparoscopy. Results Eighteen patients were enrolled in this study. Eight patients had measurable lymph node metastases by the RECIST criteria and computed tomography (CT) showed that five (62.5%) displayed a major response to the treatment. Out of 18 patients, 14 (78%) showed negative results on peritoneal cytology and no macroscopic PC, while the remaining four were cancer cell positive on peritoneal cytology or showed macroscopic PC even after NIPS. The median survival time of the entire group was 24.6 months. No treatment-related mortality was observed during NIPS and surgery. Conclusion This study indicated that the NIPS combined with surgery was highly active and well tolerated by advanced gastric cancer patients with PC.

Original languageEnglish
Pages (from-to)38-42
Number of pages5
JournalJournal of Surgical Oncology
Volume105
Issue number1
DOIs
Publication statusPublished - Jan 1 2012
Externally publishedYes

Fingerprint

docetaxel
Stomach Neoplasms
Carcinoma
Drug Therapy
Cell Biology
Combination Drug Therapy
Gastrectomy
Lymph Node Excision
Laparoscopy
Lymph Nodes

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Fujiwara, Y., Takiguchi, S., Nakajima, K., Miyata, H., Yamasaki, M., Kurokawa, Y., ... Doki, Y. (2012). Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. Journal of Surgical Oncology, 105(1), 38-42. https://doi.org/10.1002/jso.22057

Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. / Fujiwara, Yoshiyuki; Takiguchi, Shuji; Nakajima, Kiyokazu; Miyata, Hiroshi; Yamasaki, Makoto; Kurokawa, Yukinori; Mori, Masaki; Doki, Yuichiro.

In: Journal of Surgical Oncology, Vol. 105, No. 1, 01.01.2012, p. 38-42.

Research output: Contribution to journalArticle

Fujiwara, Y, Takiguchi, S, Nakajima, K, Miyata, H, Yamasaki, M, Kurokawa, Y, Mori, M & Doki, Y 2012, 'Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination', Journal of Surgical Oncology, vol. 105, no. 1, pp. 38-42. https://doi.org/10.1002/jso.22057
Fujiwara, Yoshiyuki ; Takiguchi, Shuji ; Nakajima, Kiyokazu ; Miyata, Hiroshi ; Yamasaki, Makoto ; Kurokawa, Yukinori ; Mori, Masaki ; Doki, Yuichiro. / Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. In: Journal of Surgical Oncology. 2012 ; Vol. 105, No. 1. pp. 38-42.
@article{8a0fc07b190c46d48956bdc00a4d37b9,
title = "Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination",
abstract = "Background Our previous phase I study indicated that combination chemotherapy with intraperitoneal docetaxel and S-1 was well tolerated by gastric cancer patients with peritoneal carcinomatosis (PC). This study evaluated the benefits of this combination chemotherapy and subsequent surgery. Patients and Methods Neoadjuvant Intra-Peritoneal and Systemic chemotherapy (NIPS) was introduced to gastric cancer patients with positive cytology or with PC. Two cycles of intraperitoneal chemotherapy with docetaxel combined with S-1, were administrated and gastrectomy with lymph node dissection was performed in cases without macroscopic PC at post-NIPS staging laparoscopy. Results Eighteen patients were enrolled in this study. Eight patients had measurable lymph node metastases by the RECIST criteria and computed tomography (CT) showed that five (62.5{\%}) displayed a major response to the treatment. Out of 18 patients, 14 (78{\%}) showed negative results on peritoneal cytology and no macroscopic PC, while the remaining four were cancer cell positive on peritoneal cytology or showed macroscopic PC even after NIPS. The median survival time of the entire group was 24.6 months. No treatment-related mortality was observed during NIPS and surgery. Conclusion This study indicated that the NIPS combined with surgery was highly active and well tolerated by advanced gastric cancer patients with PC.",
author = "Yoshiyuki Fujiwara and Shuji Takiguchi and Kiyokazu Nakajima and Hiroshi Miyata and Makoto Yamasaki and Yukinori Kurokawa and Masaki Mori and Yuichiro Doki",
year = "2012",
month = "1",
day = "1",
doi = "10.1002/jso.22057",
language = "English",
volume = "105",
pages = "38--42",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination

AU - Fujiwara, Yoshiyuki

AU - Takiguchi, Shuji

AU - Nakajima, Kiyokazu

AU - Miyata, Hiroshi

AU - Yamasaki, Makoto

AU - Kurokawa, Yukinori

AU - Mori, Masaki

AU - Doki, Yuichiro

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background Our previous phase I study indicated that combination chemotherapy with intraperitoneal docetaxel and S-1 was well tolerated by gastric cancer patients with peritoneal carcinomatosis (PC). This study evaluated the benefits of this combination chemotherapy and subsequent surgery. Patients and Methods Neoadjuvant Intra-Peritoneal and Systemic chemotherapy (NIPS) was introduced to gastric cancer patients with positive cytology or with PC. Two cycles of intraperitoneal chemotherapy with docetaxel combined with S-1, were administrated and gastrectomy with lymph node dissection was performed in cases without macroscopic PC at post-NIPS staging laparoscopy. Results Eighteen patients were enrolled in this study. Eight patients had measurable lymph node metastases by the RECIST criteria and computed tomography (CT) showed that five (62.5%) displayed a major response to the treatment. Out of 18 patients, 14 (78%) showed negative results on peritoneal cytology and no macroscopic PC, while the remaining four were cancer cell positive on peritoneal cytology or showed macroscopic PC even after NIPS. The median survival time of the entire group was 24.6 months. No treatment-related mortality was observed during NIPS and surgery. Conclusion This study indicated that the NIPS combined with surgery was highly active and well tolerated by advanced gastric cancer patients with PC.

AB - Background Our previous phase I study indicated that combination chemotherapy with intraperitoneal docetaxel and S-1 was well tolerated by gastric cancer patients with peritoneal carcinomatosis (PC). This study evaluated the benefits of this combination chemotherapy and subsequent surgery. Patients and Methods Neoadjuvant Intra-Peritoneal and Systemic chemotherapy (NIPS) was introduced to gastric cancer patients with positive cytology or with PC. Two cycles of intraperitoneal chemotherapy with docetaxel combined with S-1, were administrated and gastrectomy with lymph node dissection was performed in cases without macroscopic PC at post-NIPS staging laparoscopy. Results Eighteen patients were enrolled in this study. Eight patients had measurable lymph node metastases by the RECIST criteria and computed tomography (CT) showed that five (62.5%) displayed a major response to the treatment. Out of 18 patients, 14 (78%) showed negative results on peritoneal cytology and no macroscopic PC, while the remaining four were cancer cell positive on peritoneal cytology or showed macroscopic PC even after NIPS. The median survival time of the entire group was 24.6 months. No treatment-related mortality was observed during NIPS and surgery. Conclusion This study indicated that the NIPS combined with surgery was highly active and well tolerated by advanced gastric cancer patients with PC.

UR - http://www.scopus.com/inward/record.url?scp=83455172626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455172626&partnerID=8YFLogxK

U2 - 10.1002/jso.22057

DO - 10.1002/jso.22057

M3 - Article

C2 - 21882194

AN - SCOPUS:83455172626

VL - 105

SP - 38

EP - 42

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -